GH Research (GH Research) Debt-to-Revenue : N/A (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is GH Research Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

GH Research's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.34 Mil. GH Research's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.56 Mil. GH Research's annualized Revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.

GH Research Debt-to-Revenue Historical Data

The historical data trend for GH Research's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Debt-to-Revenue Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

N/A

GH Research Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial													N/A	N/A	N/A	N/A	N/A

Competitive Comparison of GH Research's Debt-to-Revenue

For the Biotechnology subindustry, GH Research's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where GH Research's Debt-to-Revenue falls into.

GH Research Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

GH Research's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.343	+	0.631)	/	N/A
	=	N/A

GH Research's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.336	+	0.561)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

GH Research Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of GH Research's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research (GH Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (NAS:GHRS) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

1KA:Germany

Address

28 Baggot Street Lower, Dublin, IRL, D02 NX43

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.